Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prophin
Oxford, United Kingdomprophin.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Prophin is a biotechnology company specializing in the development and production of high-quality recombinant proteins and peptides for research and therapeutic applications. The company leverages proprietary expression systems to optimize the yield and purity of complex biological molecules, serving as a critical partner for pharmaceutical and academic researchers. Prophin's core business includes contract manufacturing and the supply of specialized reagents used in drug discovery and diagnostic development. By focusing on scalable production technologies, the company aims to accelerate the transition of biological candidates from the laboratory to clinical evaluation.
- Modalities
- Recombinant proteinPeptides
- Industry
- Contract Manufacturing Organization
Beyond the preview
Go deeper on Prophin.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prophin.